Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage
- 3 May 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (28) , 4818-4827
- https://doi.org/10.1038/sj.onc.1207648
Abstract
Enforced expression of the antiapoptotic Bcl-2 family protein Mcl-1 promotes lymphomagenesis in the mouse; however, the functional role of Mcl-1 in human B-cell lymphoma remains unclear. We demonstrate that Mcl-1 is widely expressed in malignant B-cells, and high-level expression of Mcl-1 is required for B-lymphoma cell survival, since transfection of Mcl-1-specific antisense oligodeoxynucleotides was sufficient to promote apoptosis in Akata6 lymphoma cells. Mcl-1 was efficiently cleaved by caspases at evolutionarily conserved aspartic acid residues in vitro, and during cisplatin-induced apoptosis in B-lymphoma cell lines and spontaneous apoptosis of primary malignant B-cells. Overexpression of the Mcl-1 cleavage product that accumulated during apoptosis was sufficient to kill cells. Therefore, Mcl-1 is an essential survival molecule for B-lymphoma cells and is cleaved by caspases to a death-promoting molecule during apoptosis. In contrast to Mcl-1, Bcl-2 and Bcl-XL were relatively resistant to caspase cleavage in vitro and in intact cells. Interfering with Mcl-1 function appears to be an effective means of inducing apoptosis in Mcl-1-positive B-cell lymphoma, and the unique sensitivity of Mcl-1 to caspase-mediated cleavage suggests an attractive strategy for converting it to a proapoptotic molecule.Keywords
This publication has 48 references indexed in Scilit:
- Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1Nature, 2003
- Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1Leukemia, 2003
- The triterpenoid CDDO induces apoptosis in refractory CLL B cellsBlood, 2002
- The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulationOncogene, 2002
- The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis inductionBlood, 2002
- Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell DeathJournal of Virology, 2001
- A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced ApoptosisPublished by Elsevier ,2001
- In vivo localisation and stability of human Mcl‐1 using green fluorescent protein (GFP) fusion proteinsFEBS Letters, 2000
- Caspase-mediated Cleavage of DNA Topoisomerase I at Unconventional Sites during ApoptosisJournal of Biological Chemistry, 1999
- High-Grade Malignant Non-Hodgkin’s Lymphomas Differ from Low-Grade Lymphomasin the Extent of Apoptosis andTheir Expression of bcl-2, mcl-1,bax and p53Tumor Biology, 1998